UPDATE 1-Abuse of U.S. generic-drug rules costs billions -report
July 23, 2014 at 17:12 PM EDT
WASHINGTON, July 23 (Reuters) - U.S. rules that ensure prescription medicines are not misused have been manipulated by brand-name drug companies to fight off generic competitors, costing consumers billions of dollars, according to a report released on Wednesday.